TCL Archive M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report February 27, 1976
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
